Scinai Immunotherapeutics Secures $2 Million Investment Commitment to Advance Biopharmaceutical Initiatives
Scinai Immunotherapeutics has entered into a $2 million Investment Commitment Agreement, bolstering its financial position to further develop inflammation and immunology biological products and expand its CDMO services.
Read the full story














